May 30, 2024 - Reports of a rare nervous system disorder are “more common than expected” in older U.S. adults who got the new RSV vaccines.

May 10, 2024 - (NASDAQ:MRNA) today announced it ... of the Biologics License Application (BLA) for mRNA-1345, Moderna's investigational respiratory syncytial virus (RSV) vaccine, by the previously communicated Prescription Drug User Fee Act (PDUFA) date of May 12, 2024....

September 27, 2024 - The California Department of Public Health is dedicated to optimizing the health and well-being of Californians

May 13, 2024 - The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent its approval, the biotech company said.

April 13, 2024 - Pfizer plans to file for an expanded approval of Abrysvo, which is currently approved for adults ages 60 and above and expectant mothers.

April 10, 2024 - MedImmune, the global biologics arm of AstraZeneca, today announced execution of an in-licensing agreement with Pfizer Inc for tremelimumab (CP-675,206), a CTLA-4 monoclonal antibody. Under the terms of this agreement, MedImmune will assume global development rights to tremelimumab and Pfizer ...

Find more information about AREXVY, a respiratory syncytial virus (RSV) vaccine for adults aged 60 and older. Learn about side effects, coverage, and where to get AREXVY.

September 27, 2024 - The RSV vaccine is being offered to adults who may be at risk from serious illness due to RSV infection. Read more about getting the vaccine.

September 11, 2023 - The study covers the geographical areas of Bristol, Chester and Liverpool and has 13 primary care sites and 2 secondary and tertiary care sites. The study aims to improve the understanding of the burden of RSV in infants and young children to provide data to inform future vaccination strategies.

November 22, 2019 - RSV infection is the most important cause of hospitalisation in infants and one of the leading global causes of infant mortality and as such its prevention through immunisation is a public health priority.

October 13, 2023 - Respiratory syncytial virus (RSV) seasons vary each year, but this year there are RSV vaccines to help reduce risk for severe illness. Learn more.